Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Streptococcus pneumoniae | 65 | 2021 | 714 | 10.540 |
Why?
|
Pneumococcal Infections | 43 | 2020 | 497 | 8.820 |
Why?
|
Pneumococcal Vaccines | 34 | 2021 | 391 | 6.280 |
Why?
|
Genome, Bacterial | 30 | 2024 | 760 | 4.380 |
Why?
|
Recombination, Genetic | 26 | 2020 | 1586 | 3.290 |
Why?
|
Bacteria | 26 | 2024 | 2114 | 3.150 |
Why?
|
Carrier State | 23 | 2020 | 518 | 3.100 |
Why?
|
Vaccines, Conjugate | 15 | 2020 | 333 | 2.800 |
Why?
|
Disease Outbreaks | 19 | 2021 | 1772 | 2.280 |
Why?
|
Phylogeny | 36 | 2022 | 2803 | 2.240 |
Why?
|
Serotyping | 28 | 2021 | 338 | 2.080 |
Why?
|
Escherichia coli Infections | 8 | 2020 | 532 | 1.970 |
Why?
|
Molecular Epidemiology | 10 | 2020 | 468 | 1.830 |
Why?
|
Evolution, Molecular | 22 | 2020 | 1940 | 1.780 |
Why?
|
Genetic Variation | 29 | 2020 | 6544 | 1.780 |
Why?
|
Metagenomics | 7 | 2024 | 428 | 1.590 |
Why?
|
Drug Resistance, Bacterial | 15 | 2021 | 1035 | 1.500 |
Why?
|
Genetic Speciation | 6 | 2017 | 46 | 1.410 |
Why?
|
Anti-Bacterial Agents | 27 | 2021 | 7181 | 1.380 |
Why?
|
Genomics | 14 | 2024 | 5720 | 1.370 |
Why?
|
Bacterial Typing Techniques | 11 | 2020 | 256 | 1.250 |
Why?
|
Gene Transfer, Horizontal | 9 | 2021 | 145 | 1.230 |
Why?
|
Penicillin Resistance | 3 | 2017 | 84 | 1.220 |
Why?
|
Genes, Bacterial | 13 | 2021 | 1079 | 1.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 11 | 2020 | 567 | 1.100 |
Why?
|
Models, Genetic | 15 | 2017 | 3494 | 1.020 |
Why?
|
Science | 2 | 2020 | 241 | 1.000 |
Why?
|
Biological Evolution | 8 | 2017 | 1076 | 0.930 |
Why?
|
Escherichia coli | 6 | 2020 | 4217 | 0.880 |
Why?
|
Mass Vaccination | 3 | 2021 | 105 | 0.860 |
Why?
|
Immunity, Herd | 2 | 2021 | 44 | 0.830 |
Why?
|
beta-Lactam Resistance | 3 | 2017 | 79 | 0.810 |
Why?
|
Neisseria | 3 | 2013 | 12 | 0.800 |
Why?
|
Multilocus Sequence Typing | 9 | 2015 | 100 | 0.790 |
Why?
|
Genetics, Population | 8 | 2018 | 934 | 0.780 |
Why?
|
Bacteremia | 4 | 2019 | 962 | 0.750 |
Why?
|
DNA, Bacterial | 14 | 2018 | 1465 | 0.750 |
Why?
|
Communicable Diseases | 6 | 2021 | 880 | 0.740 |
Why?
|
Selection, Genetic | 11 | 2021 | 914 | 0.720 |
Why?
|
beta-Lactams | 3 | 2020 | 160 | 0.710 |
Why?
|
Streptococcus | 3 | 2014 | 197 | 0.700 |
Why?
|
Directed Molecular Evolution | 1 | 2020 | 160 | 0.700 |
Why?
|
Microbial Sensitivity Tests | 12 | 2020 | 1877 | 0.690 |
Why?
|
Federal Government | 1 | 2020 | 260 | 0.670 |
Why?
|
Cross Infection | 6 | 2019 | 1416 | 0.650 |
Why?
|
Nasopharynx | 12 | 2020 | 379 | 0.650 |
Why?
|
Genotype | 21 | 2021 | 12951 | 0.650 |
Why?
|
Mycobacterium tuberculosis | 2 | 2020 | 1832 | 0.640 |
Why?
|
Sequence Analysis, DNA | 17 | 2020 | 4803 | 0.630 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 253 | 0.630 |
Why?
|
Genome, Viral | 2 | 2020 | 667 | 0.620 |
Why?
|
Streptococcus pyogenes | 1 | 2020 | 289 | 0.620 |
Why?
|
DNA Transposable Elements | 5 | 2021 | 748 | 0.620 |
Why?
|
Epidemiology | 2 | 2018 | 287 | 0.610 |
Why?
|
Social Responsibility | 1 | 2020 | 389 | 0.610 |
Why?
|
Staphylococcus aureus | 7 | 2018 | 1451 | 0.600 |
Why?
|
R Factors | 1 | 2017 | 44 | 0.590 |
Why?
|
Clinical Medicine | 1 | 2018 | 147 | 0.590 |
Why?
|
Pandemics | 11 | 2021 | 8388 | 0.590 |
Why?
|
Adaptation, Biological | 1 | 2018 | 153 | 0.580 |
Why?
|
Vaccination | 10 | 2021 | 3278 | 0.570 |
Why?
|
Shiga-Toxigenic Escherichia coli | 2 | 2015 | 28 | 0.570 |
Why?
|
Meningococcal Vaccines | 2 | 2007 | 95 | 0.570 |
Why?
|
Staphylococcal Infections | 6 | 2018 | 1400 | 0.550 |
Why?
|
Cluster Analysis | 11 | 2017 | 2715 | 0.540 |
Why?
|
Carbapenems | 1 | 2017 | 118 | 0.540 |
Why?
|
Contact Tracing | 4 | 2021 | 273 | 0.540 |
Why?
|
Prophages | 2 | 2014 | 38 | 0.530 |
Why?
|
Enterobacteriaceae | 1 | 2017 | 169 | 0.530 |
Why?
|
Genomic Islands | 2 | 2014 | 51 | 0.520 |
Why?
|
Epistasis, Genetic | 1 | 2018 | 365 | 0.520 |
Why?
|
Enterobacteriaceae Infections | 1 | 2017 | 187 | 0.510 |
Why?
|
Host-Pathogen Interactions | 5 | 2017 | 1477 | 0.500 |
Why?
|
Bacterial Load | 1 | 2015 | 153 | 0.500 |
Why?
|
Penicillins | 1 | 2017 | 380 | 0.490 |
Why?
|
Influenza A virus | 1 | 2018 | 456 | 0.480 |
Why?
|
Ecosystem | 5 | 2017 | 474 | 0.470 |
Why?
|
Communicable Disease Control | 4 | 2021 | 857 | 0.470 |
Why?
|
Bacterial Capsules | 5 | 2017 | 251 | 0.460 |
Why?
|
Bacterial Infections | 7 | 2015 | 1401 | 0.460 |
Why?
|
Massachusetts | 16 | 2021 | 8663 | 0.460 |
Why?
|
Infection Control | 1 | 2021 | 966 | 0.460 |
Why?
|
Humans | 125 | 2022 | 744343 | 0.440 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2020 | 3597 | 0.440 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 403 | 0.440 |
Why?
|
Archaea | 1 | 2013 | 59 | 0.430 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 428 | 0.420 |
Why?
|
Haemophilus influenzae | 1 | 2012 | 171 | 0.420 |
Why?
|
Zoonoses | 1 | 2013 | 185 | 0.410 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2018 | 810 | 0.410 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2018 | 687 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2020 | 15519 | 0.410 |
Why?
|
Indians, North American | 2 | 2012 | 355 | 0.400 |
Why?
|
Neisseria gonorrhoeae | 3 | 2020 | 238 | 0.400 |
Why?
|
Species Specificity | 6 | 2015 | 2478 | 0.390 |
Why?
|
Models, Biological | 8 | 2020 | 9583 | 0.390 |
Why?
|
Infant | 27 | 2022 | 35136 | 0.390 |
Why?
|
Influenza, Human | 3 | 2018 | 1479 | 0.380 |
Why?
|
Cell Communication | 1 | 2018 | 1621 | 0.380 |
Why?
|
Biodiversity | 2 | 2014 | 341 | 0.380 |
Why?
|
Classification | 2 | 2009 | 129 | 0.360 |
Why?
|
Fuzzy Logic | 2 | 2011 | 56 | 0.360 |
Why?
|
Uncertainty | 2 | 2014 | 734 | 0.360 |
Why?
|
Ontario | 3 | 2020 | 383 | 0.360 |
Why?
|
Computer Simulation | 11 | 2021 | 6196 | 0.350 |
Why?
|
Models, Theoretical | 4 | 2021 | 3589 | 0.350 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 401 | 0.350 |
Why?
|
Population Dynamics | 5 | 2018 | 302 | 0.330 |
Why?
|
Famous Persons | 1 | 2009 | 108 | 0.330 |
Why?
|
Otitis Media | 3 | 2008 | 277 | 0.320 |
Why?
|
Child, Preschool | 24 | 2019 | 41006 | 0.320 |
Why?
|
Public Health | 4 | 2021 | 2603 | 0.310 |
Why?
|
Bacterial Proteins | 9 | 2018 | 3848 | 0.300 |
Why?
|
Tuberculosis | 1 | 2020 | 1912 | 0.290 |
Why?
|
Chromosome Mapping | 4 | 2014 | 4740 | 0.290 |
Why?
|
Antibodies | 1 | 2015 | 2460 | 0.280 |
Why?
|
Epidemics | 3 | 2021 | 523 | 0.280 |
Why?
|
China | 3 | 2021 | 2248 | 0.280 |
Why?
|
Interspersed Repetitive Sequences | 2 | 2019 | 54 | 0.280 |
Why?
|
Sampling Studies | 2 | 2021 | 623 | 0.260 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3133 | 0.260 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3240 | 0.260 |
Why?
|
Area Under Curve | 3 | 2020 | 1654 | 0.250 |
Why?
|
Plasmids | 5 | 2021 | 2307 | 0.250 |
Why?
|
Antibodies, Bacterial | 4 | 2018 | 1470 | 0.240 |
Why?
|
Bayes Theorem | 6 | 2018 | 2309 | 0.230 |
Why?
|
Child | 25 | 2020 | 77709 | 0.220 |
Why?
|
Sequence Alignment | 3 | 2017 | 2256 | 0.210 |
Why?
|
History, 21st Century | 2 | 2018 | 1534 | 0.210 |
Why?
|
Antigens, Bacterial | 2 | 2017 | 1171 | 0.190 |
Why?
|
Conjugation, Genetic | 1 | 2021 | 126 | 0.190 |
Why?
|
Computational Biology | 4 | 2021 | 3521 | 0.190 |
Why?
|
Hong Kong | 1 | 2020 | 148 | 0.190 |
Why?
|
ROC Curve | 3 | 2019 | 3527 | 0.180 |
Why?
|
Databases, Genetic | 4 | 2020 | 1783 | 0.180 |
Why?
|
Mandatory Reporting | 1 | 2021 | 121 | 0.180 |
Why?
|
Population Density | 2 | 2014 | 196 | 0.180 |
Why?
|
Prevalence | 9 | 2018 | 15226 | 0.170 |
Why?
|
Livestock | 1 | 2019 | 19 | 0.170 |
Why?
|
Databases, Factual | 4 | 2021 | 7729 | 0.170 |
Why?
|
Communicable Diseases, Emerging | 1 | 2021 | 157 | 0.170 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2012 | 341 | 0.170 |
Why?
|
Resource Allocation | 1 | 2021 | 341 | 0.170 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
Methicillin Resistance | 2 | 2018 | 198 | 0.170 |
Why?
|
Quarantine | 1 | 2021 | 170 | 0.170 |
Why?
|
beta-Lactamases | 2 | 2019 | 306 | 0.160 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2716 | 0.160 |
Why?
|
Europe | 3 | 2020 | 3339 | 0.160 |
Why?
|
Gene Flow | 3 | 2016 | 79 | 0.160 |
Why?
|
Vaccines, Inactivated | 1 | 2018 | 184 | 0.160 |
Why?
|
British Columbia | 1 | 2018 | 244 | 0.160 |
Why?
|
Mutagenesis, Insertional | 1 | 2021 | 655 | 0.160 |
Why?
|
Polymorphism, Genetic | 2 | 2021 | 4328 | 0.160 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2002 | 1155 | 0.150 |
Why?
|
Health Care Rationing | 1 | 2021 | 437 | 0.150 |
Why?
|
United States | 11 | 2021 | 69872 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 551 | 0.150 |
Why?
|
Multigene Family | 4 | 2013 | 1102 | 0.150 |
Why?
|
Sierra Leone | 1 | 2017 | 166 | 0.150 |
Why?
|
Sentinel Surveillance | 2 | 2011 | 281 | 0.150 |
Why?
|
Alleles | 6 | 2016 | 6933 | 0.150 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 78 | 0.150 |
Why?
|
Phylogeography | 3 | 2012 | 82 | 0.150 |
Why?
|
Mutation | 8 | 2021 | 29786 | 0.140 |
Why?
|
DNA | 3 | 2018 | 7301 | 0.140 |
Why?
|
Antibody Formation | 2 | 2018 | 1402 | 0.140 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2016 | 62 | 0.140 |
Why?
|
Neutropenia | 1 | 2002 | 895 | 0.140 |
Why?
|
Viruses | 1 | 2020 | 374 | 0.140 |
Why?
|
Linkage Disequilibrium | 2 | 2020 | 1997 | 0.140 |
Why?
|
Campylobacter jejuni | 2 | 2014 | 26 | 0.140 |
Why?
|
Public Policy | 1 | 2020 | 572 | 0.140 |
Why?
|
Clone Cells | 2 | 2017 | 1692 | 0.140 |
Why?
|
Staphylococcal Skin Infections | 1 | 2016 | 75 | 0.130 |
Why?
|
Software | 5 | 2009 | 4443 | 0.130 |
Why?
|
Travel | 2 | 2020 | 788 | 0.130 |
Why?
|
Peer Review, Research | 1 | 2018 | 329 | 0.130 |
Why?
|
Incidence | 6 | 2021 | 20947 | 0.130 |
Why?
|
Survival | 1 | 2015 | 163 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.130 |
Why?
|
Models, Statistical | 3 | 2021 | 5102 | 0.130 |
Why?
|
DNA Restriction-Modification Enzymes | 1 | 2014 | 11 | 0.130 |
Why?
|
Meningitis, Bacterial | 1 | 2017 | 218 | 0.130 |
Why?
|
Shock, Septic | 1 | 2002 | 775 | 0.130 |
Why?
|
Staphylococcus epidermidis | 1 | 2015 | 117 | 0.130 |
Why?
|
Soil Microbiology | 1 | 2015 | 87 | 0.120 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2019 | 0.120 |
Why?
|
Soft Tissue Infections | 1 | 2016 | 155 | 0.120 |
Why?
|
Cefixime | 1 | 2014 | 12 | 0.120 |
Why?
|
Cephalosporin Resistance | 1 | 2014 | 17 | 0.120 |
Why?
|
Virus Diseases | 1 | 2020 | 711 | 0.120 |
Why?
|
Genetic Loci | 3 | 2019 | 2575 | 0.120 |
Why?
|
Education, Graduate | 1 | 2014 | 81 | 0.120 |
Why?
|
HIV-1 | 2 | 2010 | 6939 | 0.110 |
Why?
|
Tropism | 1 | 2013 | 41 | 0.110 |
Why?
|
Viral Load | 3 | 2020 | 3299 | 0.110 |
Why?
|
Entropy | 1 | 2014 | 209 | 0.110 |
Why?
|
Drug Resistance, Multiple | 1 | 2014 | 252 | 0.110 |
Why?
|
Stochastic Processes | 1 | 2014 | 344 | 0.110 |
Why?
|
Immunization | 1 | 2017 | 1256 | 0.110 |
Why?
|
Gene Frequency | 3 | 2020 | 3588 | 0.110 |
Why?
|
Nasal Mucosa | 1 | 2015 | 373 | 0.110 |
Why?
|
Infant, Newborn | 7 | 2018 | 25625 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2018 | 1179 | 0.110 |
Why?
|
Vaccines | 1 | 2021 | 822 | 0.110 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2013 | 1085 | 0.110 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2013 | 110 | 0.110 |
Why?
|
Swine Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
Seasons | 1 | 2018 | 1493 | 0.100 |
Why?
|
Gambia | 1 | 2011 | 98 | 0.100 |
Why?
|
Bacteriophages | 1 | 2014 | 356 | 0.100 |
Why?
|
Enterococcus faecium | 1 | 2012 | 102 | 0.100 |
Why?
|
Neisseria meningitidis | 3 | 2009 | 109 | 0.100 |
Why?
|
Vibrio cholerae O1 | 1 | 2013 | 242 | 0.100 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2015 | 329 | 0.100 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2012 | 127 | 0.100 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2014 | 954 | 0.090 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.090 |
Why?
|
Gram-Positive Bacteria | 1 | 2011 | 184 | 0.090 |
Why?
|
Animals | 11 | 2019 | 168757 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19905 | 0.090 |
Why?
|
Gene Pool | 1 | 2009 | 35 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2014 | 638 | 0.090 |
Why?
|
Fimbriae Proteins | 1 | 2010 | 134 | 0.090 |
Why?
|
Gonorrhea | 1 | 2014 | 335 | 0.090 |
Why?
|
Capsid | 1 | 2012 | 436 | 0.090 |
Why?
|
Extinction, Biological | 1 | 2009 | 32 | 0.090 |
Why?
|
History, 18th Century | 1 | 2009 | 214 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2020 | 77449 | 0.090 |
Why?
|
Genetics, Microbial | 1 | 2009 | 60 | 0.080 |
Why?
|
Male | 20 | 2020 | 350118 | 0.080 |
Why?
|
Universities | 1 | 2014 | 956 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1797 | 0.080 |
Why?
|
Typhoid Fever | 1 | 2010 | 197 | 0.080 |
Why?
|
Capsid Proteins | 1 | 2012 | 479 | 0.080 |
Why?
|
Proteome | 1 | 2018 | 1799 | 0.080 |
Why?
|
Burkholderia | 1 | 2008 | 38 | 0.080 |
Why?
|
Base Sequence | 3 | 2014 | 12797 | 0.080 |
Why?
|
Finland | 2 | 2008 | 602 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2011 | 795 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2011 | 767 | 0.080 |
Why?
|
Sequence Analysis | 1 | 2009 | 256 | 0.080 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9313 | 0.080 |
Why?
|
Malawi | 2 | 2020 | 282 | 0.080 |
Why?
|
Fimbriae, Bacterial | 1 | 2008 | 138 | 0.080 |
Why?
|
Virulence | 3 | 2010 | 1333 | 0.080 |
Why?
|
Female | 19 | 2020 | 380194 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15076 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3218 | 0.070 |
Why?
|
History, 19th Century | 1 | 2009 | 720 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 18111 | 0.070 |
Why?
|
Cytokines | 1 | 2002 | 7322 | 0.070 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2009 | 798 | 0.070 |
Why?
|
Rabbits | 1 | 2013 | 4894 | 0.070 |
Why?
|
Cholera | 1 | 2013 | 785 | 0.070 |
Why?
|
Africa | 2 | 2020 | 673 | 0.070 |
Why?
|
Conjunctivitis, Bacterial | 1 | 2006 | 24 | 0.070 |
Why?
|
Young Adult | 9 | 2020 | 56430 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2020 | 57776 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.070 |
Why?
|
RNA, Viral | 3 | 2021 | 2902 | 0.070 |
Why?
|
Diarrhea | 1 | 2013 | 1348 | 0.070 |
Why?
|
Conjunctivitis | 1 | 2006 | 158 | 0.060 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.060 |
Why?
|
HIV Infections | 2 | 2010 | 16718 | 0.060 |
Why?
|
Algorithms | 7 | 2017 | 13881 | 0.060 |
Why?
|
Students | 1 | 2014 | 1654 | 0.060 |
Why?
|
Immunoglobulin G | 4 | 2018 | 4560 | 0.060 |
Why?
|
Genetic Linkage | 2 | 2010 | 2421 | 0.060 |
Why?
|
Age Factors | 2 | 2021 | 18370 | 0.060 |
Why?
|
Adult | 11 | 2020 | 214055 | 0.060 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.060 |
Why?
|
Selection Bias | 1 | 2005 | 371 | 0.060 |
Why?
|
Middle Aged | 9 | 2020 | 213383 | 0.060 |
Why?
|
Polysaccharides, Bacterial | 1 | 2006 | 578 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2018 | 13989 | 0.050 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5319 | 0.050 |
Why?
|
Aged | 7 | 2020 | 163280 | 0.050 |
Why?
|
Israel | 2 | 2020 | 796 | 0.050 |
Why?
|
Age Distribution | 2 | 2020 | 2902 | 0.050 |
Why?
|
History, 20th Century | 1 | 2009 | 2740 | 0.050 |
Why?
|
Prospective Studies | 5 | 2018 | 53288 | 0.050 |
Why?
|
Program Evaluation | 1 | 2010 | 2488 | 0.050 |
Why?
|
Adolescent | 7 | 2018 | 85781 | 0.050 |
Why?
|
INDEL Mutation | 2 | 2014 | 279 | 0.050 |
Why?
|
Synteny | 1 | 2021 | 79 | 0.050 |
Why?
|
Virus Shedding | 1 | 2021 | 108 | 0.050 |
Why?
|
Rhode Island | 1 | 2021 | 347 | 0.050 |
Why?
|
Drug Resistance | 1 | 2006 | 1609 | 0.050 |
Why?
|
Ships | 1 | 2020 | 61 | 0.050 |
Why?
|
Cohort Studies | 2 | 2019 | 40561 | 0.050 |
Why?
|
Macrolides | 1 | 2021 | 201 | 0.050 |
Why?
|
Likelihood Functions | 2 | 2014 | 1005 | 0.040 |
Why?
|
Chromosomes, Bacterial | 1 | 2021 | 282 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2022 | 623 | 0.040 |
Why?
|
Germany | 1 | 2021 | 862 | 0.040 |
Why?
|
Aluminum Hydroxide | 1 | 2018 | 58 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 25043 | 0.040 |
Why?
|
Operon | 2 | 2010 | 363 | 0.040 |
Why?
|
Metagenome | 1 | 2021 | 418 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2002 | 1263 | 0.040 |
Why?
|
Trans-Activators | 1 | 2008 | 2924 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 441 | 0.040 |
Why?
|
Middle East | 1 | 2018 | 219 | 0.040 |
Why?
|
Penicillin-Binding Proteins | 1 | 2018 | 137 | 0.040 |
Why?
|
Tetracycline Resistance | 1 | 2016 | 20 | 0.040 |
Why?
|
Acinetobacter | 1 | 2016 | 39 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2018 | 411 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2751 | 0.040 |
Why?
|
Internet | 1 | 2009 | 3064 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2017 | 119 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1345 | 0.030 |
Why?
|
Mutagens | 1 | 2016 | 168 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1623 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
Ecological and Environmental Phenomena | 1 | 2015 | 12 | 0.030 |
Why?
|
Arctic Regions | 1 | 2015 | 25 | 0.030 |
Why?
|
Probability | 1 | 2021 | 2505 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 12261 | 0.030 |
Why?
|
Asia | 1 | 2016 | 610 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2016 | 354 | 0.030 |
Why?
|
Chloramphenicol Resistance | 1 | 2014 | 6 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2297 | 0.030 |
Why?
|
Soil | 1 | 2015 | 106 | 0.030 |
Why?
|
Iceland | 1 | 2014 | 183 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6171 | 0.030 |
Why?
|
Genetic Fitness | 1 | 2015 | 121 | 0.030 |
Why?
|
Genome, Fungal | 1 | 2015 | 204 | 0.030 |
Why?
|
Birds | 1 | 2014 | 163 | 0.030 |
Why?
|
Genes, Fungal | 1 | 2015 | 455 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2018 | 1000 | 0.030 |
Why?
|
Haplotypes | 1 | 2020 | 2779 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.030 |
Why?
|
New York City | 1 | 2015 | 710 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7149 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1808 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2017 | 822 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4217 | 0.030 |
Why?
|
Turkey | 1 | 2012 | 237 | 0.030 |
Why?
|
Odds Ratio | 1 | 2005 | 9849 | 0.030 |
Why?
|
Chickens | 1 | 2014 | 865 | 0.030 |
Why?
|
Cytoplasm | 1 | 2016 | 1539 | 0.030 |
Why?
|
New Mexico | 1 | 2011 | 86 | 0.030 |
Why?
|
Arizona | 1 | 2011 | 108 | 0.030 |
Why?
|
California | 1 | 2016 | 1402 | 0.030 |
Why?
|
Streptococcus Phages | 1 | 2011 | 4 | 0.020 |
Why?
|
Complement C1q | 1 | 2011 | 92 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 2959 | 0.020 |
Why?
|
Haiti | 1 | 2013 | 553 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1028 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 2014 | 862 | 0.020 |
Why?
|
Enterococcus faecalis | 1 | 2012 | 251 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2011 | 125 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4420 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.020 |
Why?
|
Neisseria lactamica | 1 | 2009 | 1 | 0.020 |
Why?
|
Epitopes | 1 | 2017 | 2571 | 0.020 |
Why?
|
DNA Replication | 1 | 2016 | 1399 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5952 | 0.020 |
Why?
|
Viridans Streptococci | 1 | 2009 | 15 | 0.020 |
Why?
|
Peer Group | 1 | 2014 | 635 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Salmonella typhi | 1 | 2010 | 201 | 0.020 |
Why?
|
Risk Assessment | 1 | 2010 | 23338 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13408 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3610 | 0.020 |
Why?
|
Child Day Care Centers | 1 | 2009 | 123 | 0.020 |
Why?
|
Cattle | 1 | 2014 | 3922 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2014 | 1011 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2009 | 313 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18029 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 690 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 329 | 0.020 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2006 | 143 | 0.020 |
Why?
|
Bacterial Adhesion | 1 | 2008 | 316 | 0.020 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2007 | 122 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2002 | 19229 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2009 | 12245 | 0.020 |
Why?
|
Uganda | 1 | 2010 | 1243 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.020 |
Why?
|
Family Characteristics | 1 | 2010 | 1000 | 0.020 |
Why?
|
Learning | 1 | 2014 | 1713 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3870 | 0.020 |
Why?
|
Family Health | 1 | 2009 | 1282 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1312 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1254 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 824 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1782 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2014 | 3690 | 0.010 |
Why?
|
Swine | 1 | 2012 | 5917 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 1005 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5974 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15997 | 0.010 |
Why?
|
Health Surveys | 1 | 2010 | 4037 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7880 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9386 | 0.010 |
Why?
|
Neutrophils | 1 | 2011 | 3719 | 0.010 |
Why?
|
Biomedical Research | 1 | 2014 | 3309 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 72290 | 0.010 |
Why?
|
Hospitalization | 1 | 2015 | 10262 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39050 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81183 | 0.000 |
Why?
|